SCHEMBL2995067

SCHEMBL2995067

Cc1c(C(=O)C(=O)NN2CCCCC2)c2cc(Cl)ccc2n1Cc1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.51
LMNA P02545 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 4/20 0.42
PKM P14618 3/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
PLA2G2A P14555 2/20 0.41
RGS12 O14924 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
GNAI1 P63096 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3011391 0.94 FAAH (0.58) FAAHLMNAMEN1KMT2AHTT
SCHEMBL4099162 0.90 PLA2G2A (0.56) FAAHLMNAMEN1KMT2AHTT
SCHEMBL4388976 0.87 ALDH1A1 (0.50) FAAHLMNAMEN1KMT2AMAPT
SCHEMBL4083893 0.82 CNR2 (0.50) FAAHLMNAMEN1KMT2AMAPT
SCHEMBL4083374 0.81 FAAH (0.52) FAAHLMNAMEN1KMT2AHTT
SCHEMBL2159984 0.78 FAAH (0.64) FAAHMEN1KMT2AHTTSMN1; SMN2
SCHEMBL3001909 0.77 FAAH (0.68) FAAHLMNAMEN1KMT2AHTT
SCHEMBL2992971 0.77 FAAH (0.57) FAAHMEN1KMT2AHTTMAPT
SCHEMBL6189878 0.75 FAAH (0.51) FAAHLMNAMEN1KMT2AHTT
SCHEMBL2168048 0.75 FAAH (0.73) FAAHLMNAMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US claimed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 FAAH 109/4885LMNA 3450/4885MEN1 3970/4885
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 FAAH 1/4885LMNA 4089/4885MEN1 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.